EC Number |
Activating Compound |
Reference |
---|
3.4.21.7 | Aprotinin |
augments binding of hepatocytes from mice to immobilized plasmin |
685347 |
3.4.21.7 | urokinase-type plasminogen activator |
cleaves plasminogen to give active plasmin |
717845 |
3.4.21.7 | urokinase-type plasminogen activator |
converts plasminogen bound to a plasminogen receptor into plasmin |
731653 |
3.4.21.7 | more |
Glu-plasminogen incubated with adherent cells, i.e. CHO-K1, HEK-293 and HMEC-1 cells, is converted into plasmin for activation by constitutively expressed tPA, i.e. tissue-type plasminogen activator, or uPA, i.e. urokinase-type plasminogen activator |
717216 |
3.4.21.7 | high molecular weight urokinase-type plasminogen activator |
induces a significant increase in plasmin activity in unstimulated or lipopolysaccharide-stimulated monocytes |
688153 |
3.4.21.7 | low molecular weight urokinase-type plasminogen activator |
induces a significant increase in plasmin activity in unstimulated or lipopolysaccharide-stimulated monocytes |
688153 |
3.4.21.7 | Efb protein |
plasminogen bound to Efb protein is converted to plasmin |
732706 |
3.4.21.7 | urokinase-type plasminogen activator |
plasminogen bound to immunoglobulin-like proteins LigA and LigB is converted to proteolytic active plasmin in the presence of urokinase-type plasminogen activator |
753781 |
3.4.21.7 | Sbi protein |
plasminogen bound to Sbi protein is converted to plasmin |
732706 |
3.4.21.7 | fragment X |
profibrinolytic effect with plasmin. Rates of plasmin formation increase with increasing fragment X concentrations. Plasmin degrades clots containing fragment X more rapidly than fibrin clots |
685074 |